Authors:
Lebret, T
Herve, JM
Lugagne, PM
Barre, P
Butreau, M
Botto, H
Citation: T. Lebret et al., Extracorporeal shock wave lithotripsy (ESWL) in the treatment of La Peyronie disease. Use of a standard lithotriptor (Siemens multiline) on << young >> plaques (less than 6 months)., PROG UROL, 10(1), 2000, pp. 65-71
Authors:
Lebret, T
Becette, V
Herve, JM
Molinie, V
Barre, P
Lugagne, PM
Gentille, A
Baglin, AC
Botto, H
Citation: T. Lebret et al., Prognostic value of MIB-1 antibody labeling index to predict response to bacillus Calmette-Guerin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer, EUR UROL, 37(6), 2000, pp. 654-659
Authors:
Lebret, T
Bohin, D
Kassardjian, Z
Herve, JM
Molinie, V
Barre, P
Lugagne, PM
Botto, H
Citation: T. Lebret et al., Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations, J UROL, 163(1), 2000, pp. 63-67
Authors:
Lebret, T
Becette, V
Colau, A
Herve, JM
Molinie, V
Barre, P
Lugagne-Delpon, PM
Gentile, A
Baglin, C
Botto, H
Citation: T. Lebret et al., Study of monoclonal antibody Ki67 immunolabelling of renal cell carcinomaswith and without renal vein thrombosis., PROG UROL, 9(4), 1999, pp. 649-654
Authors:
Lebret, T
Herve, JM
Yonneau, L
Colau, A
Kassardjian, Z
Barre, P
Lugagne-Delpon, PM
Botto, H
Citation: T. Lebret et al., Erectile dysfunction after radical prostatectomy: value of preoperative programming of intracavernous injections., PROG UROL, 9(3), 1999, pp. 483